Striverdi Respimat
Striverdi Respimat is an inhalation spray containing olodaterol, a long-acting beta2-adrenergic agonist (LABA). It works by relaxing the muscles of the airways in the lungs to make breathing easier. It is used as a daily maintenance therapy and should not be used as a rescue inhaler for sudden asthma or COPD attacks.
Dosage by Body Weight
The recommended dose is 2 inhalations (puffs) once daily at the same time each day. Do not use more than 2 inhalations in a 24-hour period.
- Body Weight
- Below 5 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- COPD is an adult disease; safety and efficacy of this medication have not been established in pediatric patients.
- Body Weight
- 5-7 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- COPD is an adult disease; safety and efficacy of this medication have not been established in pediatric patients.
- Body Weight
- 8-10 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- COPD is an adult disease; safety and efficacy of this medication have not been established in pediatric patients.
- Body Weight
- 11-15 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- COPD is an adult disease; safety and efficacy of this medication have not been established in pediatric patients.
- Body Weight
- 16-20 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- COPD is an adult disease; safety and efficacy of this medication have not been established in pediatric patients.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not indicated | N/A | COPD is an adult disease; safety and efficacy of this medication have not been established in pediatric patients. |
| 5-7 kg | Not indicated | N/A | COPD is an adult disease; safety and efficacy of this medication have not been established in pediatric patients. |
| 8-10 kg | Not indicated | N/A | COPD is an adult disease; safety and efficacy of this medication have not been established in pediatric patients. |
| 11-15 kg | Not indicated | N/A | COPD is an adult disease; safety and efficacy of this medication have not been established in pediatric patients. |
| 16-20 kg | Not indicated | N/A | COPD is an adult disease; safety and efficacy of this medication have not been established in pediatric patients. |
Formulation
Purpose
Long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Generic Name
OlodaterolScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.